Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flora E van Leeuwen

Showing results (1-10 of 367) with videos related to

Pageof 37
Sort By:
Seminars in Hematology|August 7, 2016
Hodgkin lymphoma: Late effects of treatment and guidelines for surveillanceAndrea K Ng, Flora E van Leeuwen
JAMA|August 12, 2004
Effects of estrogen-only treatment in postmenopausal womenMatti A Rookus, Flora E van Leeuwen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2016
Anthracyclines and Alkylating Agents: New Risk Factors for Breast Cancer in Childhood Cancer Survivors?Flora E van Leeuwen, Cécile M Ronckers
Hematological Oncology|June 8, 2017
Late sequelae in Hodgkin lymphoma survivorsFlora E van Leeuwen, Andrea K Ng
Lancet (London, England)|October 25, 2003
Breast cancer and hormone-replacement therapy: the Million Women StudyFlora E Van Leeuwen, Matti A Rookus
Hematology. American Society of Hematology. Education Program|December 4, 2016
Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatmentFlora E van Leeuwen, Andrea K Ng
Hematology/Oncology Clinics of North America|October 3, 2007
Are we improving the long-term burden of Hodgkin's lymphoma patients with modern treatment?Berthe M P Aleman, Flora E van Leeuwen
Aesthetic Surgery Journal|October 25, 2021
Silicone Particle Migration: A Misleading ReportJonathan Spoor, Daphne de Jong, Flora E van Leeuwen
Journal of the National Cancer Institute|July 3, 2003
Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersMatti A Rookus, Richard Brohet, Flora E van Leeuwen
Nederlands Tijdschrift Voor Geneeskunde|May 2, 2022
[Silicone breast implants: the importance of nuanced reporting]Jonathan Spoor, Daphne de Jong, Flora E van Leeuwen
Pageof 37

Showing results (1-10 of 367) with videos related to

Sort By:
Pageof 37
Seminars in Hematology|August 7, 2016
Hodgkin lymphoma: Late effects of treatment and guidelines for surveillanceAndrea K Ng, Flora E van Leeuwen
JAMA|August 12, 2004
Effects of estrogen-only treatment in postmenopausal womenMatti A Rookus, Flora E van Leeuwen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2016
Anthracyclines and Alkylating Agents: New Risk Factors for Breast Cancer in Childhood Cancer Survivors?Flora E van Leeuwen, Cécile M Ronckers
Hematological Oncology|June 8, 2017
Late sequelae in Hodgkin lymphoma survivorsFlora E van Leeuwen, Andrea K Ng
Lancet (London, England)|October 25, 2003
Breast cancer and hormone-replacement therapy: the Million Women StudyFlora E Van Leeuwen, Matti A Rookus
Hematology. American Society of Hematology. Education Program|December 4, 2016
Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatmentFlora E van Leeuwen, Andrea K Ng
Hematology/Oncology Clinics of North America|October 3, 2007
Are we improving the long-term burden of Hodgkin's lymphoma patients with modern treatment?Berthe M P Aleman, Flora E van Leeuwen
Aesthetic Surgery Journal|October 25, 2021
Silicone Particle Migration: A Misleading ReportJonathan Spoor, Daphne de Jong, Flora E van Leeuwen
Journal of the National Cancer Institute|July 3, 2003
Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersMatti A Rookus, Richard Brohet, Flora E van Leeuwen
Nederlands Tijdschrift Voor Geneeskunde|May 2, 2022
[Silicone breast implants: the importance of nuanced reporting]Jonathan Spoor, Daphne de Jong, Flora E van Leeuwen
Pageof 37